Proton Pump Inhibitors Market, by Type, by Disease Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED: May 28, 2022

PAGES: 175 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global proton pump inhibitor market includes various drugs which are prescribed by healthcare professionals for treatments related to various gastrointestinal disorders such as duodenal ulcers, peptic ulcers, NSAIDS induced ulcers, and gasteroesophageal reflux disease. Proton pump inhibitors are a class of drugs that act on cell lining of stomach and reduce stomach acid in patients suffering from gastro-intestinal disorders. Proton pump inhibitors include drugs such as esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazol.

Market Dynamics

The global proton pump inhibitor market is expected to witness significant growth during the forecast period owing to focus of generic drug manufactures on obtaining approvals and launching products for treatment of gastro-intestinal diseases to strengthen their position in the global proton inhibitor market. For instance, in March 2020, Rosemont Pharmaceuticals, a pharmaceutical company, launched omeprazole powder for oral suspension, PPI approved for use on mg/kg basis and used in treatment of patients in age groups such as pediatric, adults. The omeprazole powder oral suspension is also licensed for use with percutaneous endoscopic gastonomy (PEG) and nasograstic (NG) tubes.

Key features of the study:

This report provides in-depth analysis of the global proton pump inhibitor market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global proton pump inhibitor market based on the following parameters - company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are AstraZeneca PLC/AB, Bayer AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Eisai Pharmaceuticals India Pvt. Ltd, Santarus, Inc., Wyeth, LLC, Janssen Pharmaceutica, Takeda Pharmaceutical Company Limited, Sanofi S.A., Aurobindo Pharma, Perrigo Company plc, Dr. Reddy's Laboratories
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, market expansion, and marketing tactics
The global proton pump inhibitor market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton pump inhibitor market.

Detailed Segmentation:

Global Proton Pump Inhibitor Market, By Type:
- Omeprazole
- Pantaprazole
- Rabeprazole
- Dexlansoprazole
- lansoprazole
- Others
Global Proton Pump Inhibitor Market, By Disease Indication:
- Ulcers
- Gastroesophageal Reflux Disease
- Others
Global Proton Pump Inhibitor Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Proton Pump Inhibitor Market, By Region:
- North America
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country/Region:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Type:
  - Omeprazole
  - Pantaprazole
  - Rabeprazole
  - Dexlansoprazole
  - lansoprazole
  - Others
  - By Disease Indication:
  - Ulcers
  - Gastroesophageal Reflux Disease
  - Others
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Others
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- AstraZeneca PLC/AB *
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Novo Nordisk A/S
- Bayer AG
- Pfizer Inc.
- Cadila Pharmaceuticals Limited
- Eisai Pharmaceuticals India Pvt. Ltd
- Santarus, Inc.
- Wyeth, LLC
- Janssen Pharmaceutica
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Aurobindo Pharma
- Perrigo Company plc
- Dr. Reddy's Laboratories
- Aralez Pharmaceuticals Inc.
- RedHill Biopharma Ltd (ADR)
- Cipla Limited

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4225

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Disease Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Technological Evolution
Regulatory Scenario
Key Developments
Collaboration and Acquisition
Diagnosis Rate/Ratio
Pipeline Analysis
PEST Analysis
Reimbursement Scenario

4. Global Proton Pump Inhibitors Market, Impact of COVID-19 Pandemic

COVID-19 Impact
Economic Impact
Demand and Supply Impact Analysis

5. Global Proton Pump Inhibitors Market, By Type, 2017 - 2028 (US$ Bn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Omeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Pantaprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Rabeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Dexlansoprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Lansoprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

6. Global Proton Pump Inhibitors Market, By Disease Indication, 2017 - 2028 (US$ Bn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Gastesophageal Reflux Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

7. Global Proton Pump Inhibitors Market, By Distribution Channel, 2017 - 2028 (US$ Bn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

8. Global Proton Pump Inhibitors Market, By Region, 2017 - 2028 (US$ Bn)

Introduction
Market Share Analysis, By Country, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Countries, 2017 - 2028
North America
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- U.S.
- Canada
Latin America
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Company Profiles
- AstraZeneca PLC/AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cadila Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eisai Pharmaceuticals India Pvt. Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Santarus, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Wyeth, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Pharmaceutica
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Perrigo Company plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aralez Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RedHill Biopharma Ltd (ADR)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies